The Experts below are selected from a list of 4002 Experts worldwide ranked by ideXlab platform

Margaret Rasmussen - One of the best experts on this subject based on the ideXlab platform.

  • absence of Fluoride Varnish related adverse events in caries prevention trials in young children united states
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Francisco Ramosgomez, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

  • Absence of Fluoride Varnish–Related Adverse Events in Caries Prevention Trials in Young Children, United States
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Francisco Ramos-gomez, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

Raul I Garcia - One of the best experts on this subject based on the ideXlab platform.

  • absence of Fluoride Varnish related adverse events in caries prevention trials in young children united states
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Francisco Ramosgomez, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

  • Absence of Fluoride Varnish–Related Adverse Events in Caries Prevention Trials in Young Children, United States
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Francisco Ramos-gomez, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

Francisco Ramosgomez - One of the best experts on this subject based on the ideXlab platform.

  • absence of Fluoride Varnish related adverse events in caries prevention trials in young children united states
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Francisco Ramosgomez, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

  • Fluoride Varnish efficacy in preventing early childhood caries
    Journal of Dental Research, 2006
    Co-Authors: Jane A Weintraub, Francisco Ramosgomez, Sara G Shain, C I Hoover, John D. B. Featherstone, Stuart A Gansky
    Abstract:

    To determine the efficacy of Fluoride Varnish (5% NaF, Duraphat®, Colgate) added to caregiver counseling to prevent early childhood caries, we conducted a two-year randomized, dental-examiner-masked clinical trial. Initially, 376 caries-free children, from low-income Chinese or Hispanic San Francisco families, were enrolled (mean age ± standard deviation, 1.8 ± 0.6 yrs). All families received counseling, and children were randomized to the following groups: no Fluoride Varnish, Fluoride Varnish once/year, or Fluoride Varnish twice/year. An unexpected protocol deviation resulted in some children receiving less active Fluoride Varnish than assigned. Intent-to-treat analyses showed a Fluoride Varnish protective effect in caries incidence, p < 0.01. Analyzing the number of actual, active Fluoride Varnish applications received resulted in a dose-response effect, p < 0.01. Caries incidence was higher for ‘counseling only’ vs. ‘counseling + Fluoride Varnish assigned once/year’ (OR = 2.20, 95% CI 1.19–4.08) and ‘...

Patricia A Braun - One of the best experts on this subject based on the ideXlab platform.

  • absence of Fluoride Varnish related adverse events in caries prevention trials in young children united states
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Francisco Ramosgomez, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

  • Absence of Fluoride Varnish–Related Adverse Events in Caries Prevention Trials in Young Children, United States
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Francisco Ramos-gomez, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

Tamanna Tiwari - One of the best experts on this subject based on the ideXlab platform.

  • absence of Fluoride Varnish related adverse events in caries prevention trials in young children united states
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Francisco Ramosgomez, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.

  • Absence of Fluoride Varnish–Related Adverse Events in Caries Prevention Trials in Young Children, United States
    Preventing Chronic Disease, 2017
    Co-Authors: Raul I Garcia, Steven E Gregorich, Patricia A Braun, Anne Wilson, Judith Albino, Tamanna Tiwari, M Harper, Terrence S Batliner, Francisco Ramos-gomez, Margaret Rasmussen
    Abstract:

    INTRODUCTION: Fluoride Varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analyses and recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to Fluoride Varnish treatment in young children. METHODS: We determined the incidence of adverse events related to Fluoride Varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of Fluoride Varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each Fluoride Varnish treatment. RESULTS: A total of 2,424 community-dwelling, dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 Fluoride Varnish treatments. On average, each child received 4.2 Fluoride Varnish treatments. We found zero Fluoride Varnish-related adverse events. CONCLUSION: Fluoride Varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.